Buscar
Exicure Inc
XCURAñadir a la lista de seguimiento
1.910USD
-0.110-5.56%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
12.17MCap. mercado
PérdidaP/E TTM
Más Datos de Exicure Inc Compañía
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Información de Exicure Inc
Símbolo de cotizaciónXCUR
Nombre de la empresaExicure Inc
Fecha de salida a bolsaMay 09, 2018
Director ejecutivoYoo (Andy)
Número de empleados7
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 09
Dirección2430 N. Halsted St.
CiudadCHICAGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal60614
Teléfono18476731707
Sitio Webhttps://www.exicuretx.com/
Símbolo de cotizaciónXCUR
Fecha de salida a bolsaMay 09, 2018
Director ejecutivoYoo (Andy)
Ejecutivos de Exicure Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Exicure Inc?
Los cinco principales accionistas de Exicure Inc son: Mr. Dongho Lee